The Medacta International GMK Sphere Post-Marketing Surveillance Study
The Medacta International GMK Sphere Post-Marketing Surveillance Study
Active, not recruiting · NCT02199600 · Registry updated 2024-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Medacta International GMK Sphere Post-Marketing Surveillance Study | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2024-12-16 | NCT02199600 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medacta International SA | 31 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Maria Middelares | Ghent | Belgium | 44 |
| Royal London Hospital | Whitechapel | United Kingdom | 1 |
| Royal National Orthopaedic Hospital NHS Trust | Stanmore | United Kingdom | 1 |
| The Elective Orthopaedic Centre (EOC) | Epsom | United Kingdom | 3 |